Top Industry Leaders in the Eye Cancer Market
Latest Eye Cancer Companies Update
Roche partners with MacRegenics collaboration focuses on developing a novel gene therapy for choroidal melanoma, potentially offering a one-time curative treatment option.
Novartis collaborates with MeiraGTx partnership aims to develop a novel gene therapy for retinoblastoma, offering a non-invasive and potentially curative approach for children with this eye cancer.
List of Eye Cancer Key Companies in the Market
- Novartis AG (Switzerland)
- Spectrum Pharmaceuticals Inc. (U.S.)
- GlaxoSmithKline Plc. (U.K.)
- Bayer AG (Germany)
- Amgen Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Eli Lilly and Company (U.S.)
- AstraZeneca Plc. (U.K.)
- Hoffmann-La Roche Ltd. (Switzerland)
- Janssen Biotech Inc. (U.S.)
- Sanofi (France)
- AbbVie Inc. (U.S.)
- Takeda Pharmaceuticals (Japan)
- Pfizer Inc. (U.S.)
- Merck & Co. Inc. (U.S.)
- Oncomed Pharmaceuticals (U.S.)
- Immunomedics (U.S.)